Incidence of cereblon protein in intensive care patients: a cross-sectional study

被引:0
作者
Ayvat, P. [1 ]
Diniz, G. [2 ]
Gulmez, H. [3 ]
Yurtlu, D. Arslan [4 ]
Asar, K. [5 ]
Katircioglu, K. [6 ]
Ece, C. [6 ]
Sofuoglu, Z. [7 ]
机构
[1] Izmir Democracy Univ, Sch Med, Dept Anesthesiol, Izmir, Turkiye
[2] Izmir Democracy Univ, Sch Med, Dept Pathol, Izmir, Turkiye
[3] Izmir Democracy Univ, Sch Med, Dept Family Med, Izmir, Turkiye
[4] Izmir Ataturk Educ & Res Hosp, Dept Anesthesiol, Izmir, Turkiye
[5] Izmir Buca Seyfi Demirsoy Educ & Res Hosp, Dept Anesthesiol, Izmir, Turkiye
[6] Izmir Tinaztepe Univ, Sch Med, Dept Anesthesiol, Izmir, Turkiye
[7] Izmir Democracy Univ, Sch Med, Dept Publ Hlth, Izmir, Turkiye
关键词
Cereblon; CRBN; Critical care; Sepsis; Mortality; LENALIDOMIDE; THALIDOMIDE; IDENTIFICATION; UBIQUITINATION; RESISTANCE; EXPRESSION; SEPSIS; CRBN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: Sepsis remains a com-mon cause of death. The cereblon (CRBN) protein, which is involved in important cellular processes, plays a role in sepsis. This cross-sectional study aimed to show the CRBN protein expression and its effects on patients in the intensive care unit.PATIENTS AND METHODS: Samples were taken by deep tracheal aspiration from patients. The presence of CRBN was pathologically inves-tigated using immunohistochemical tests and polyclonal antibodies against CRBN. The rela-tionship between gender, sepsis, steroid, sur-vival and the presence of CRBN was examined.RESULTS: Respiratory and neurologic diseas-es were the most common reasons for admission. Acinetobacter was the most frequent microorgan-ism. In patients with more than normal inflamma-tory cells, a negative correlation was observed between CRBN expression and leukocyte rate (p=0.031). In patients with CRBN, there was no cor-relation between steroid and mortality, APACHE/ Glasgow score, hospital stay length, and ICU.CONCLUSIONS: Although the prognosis for sepsis is better in CRBN-deficiency animals, the presence of CRBN in humans does not affect it. In our study, CRBN decreased as inflammatory cells increased in the patient's aspiration mate-rial. The response to steroids, an immunomodu-lator, did not change with the presence of the im-munomodulator target molecule, CRBN. There-fore, using immunomodulators in the treatment of sepsis should be reconsidered.
引用
收藏
页码:6081 / 6091
页数:11
相关论文
共 30 条
[1]   Mouse Monoclonal Antibodies Generated from Full Length Human Cereblon: Detection of Cereblon Protein in Patients with Multiple Myeloma [J].
Chang, Xiubao ;
Xu, Qinqin ;
Hou, Yuexian ;
Li, Cynthia ;
Xu, Ye ;
Stewart, A. Keith .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09)
[2]   Assessment of Global Incidence and Mortality of Hospital-treated Sepsis [J].
Fleischmann, Carolin ;
Scherag, Andre ;
Adhikari, Neill K. J. ;
Hartog, Christiane S. ;
Tsaganos, Thomas ;
Schlattmann, Peter ;
Angus, Derek C. ;
Reinhart, Konrad .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (03) :259-272
[3]   Cereblon deficiency confers resistance against polymicrobial sepsis by the activation of AMP activated protein kinase and heme-oxygenase-1 [J].
Gil, Minchan ;
Kim, Yun Kyu ;
Kim, Ha Yeong ;
Pak, Hyo-Kyung ;
Park, Chan-Sik ;
Lee, Kyung Jin .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (01) :976-981
[4]   Circ_0114428 Regulates Sepsis-Induced Kidney Injury by Targeting the miR-495-3p/CRBN Axis [J].
He, Yan ;
Sun, Yuanzhu ;
Peng, Jun .
INFLAMMATION, 2021, 44 (04) :1464-1477
[5]   High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone [J].
Heintel, Daniel ;
Rocci, Alberto ;
Ludwig, Heinz ;
Bolomsky, Arnold ;
Caltagirone, Simona ;
Schreder, Martin ;
Pfeifer, Sabine ;
Gisslinger, Heinz ;
Zojer, Niklas ;
Jaeger, Ulrich ;
Palumbo, Antonio .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (05) :695-700
[6]   Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma [J].
Huang, Shang-Yi ;
Lin, Chung-Wu ;
Lin, Hsiu-Hsia ;
Yao, Ming ;
Tang, Jih-Luh ;
Wu, Shang-Ju ;
Chen, Yao-Chang ;
Lu, Hsiao-Yun ;
Hou, Hsin-An ;
Chen, Chien-Yuan ;
Chou, Wen-Chien ;
Tsay, Woei ;
Chou, Sheng-Je ;
Tien, Hwei-Fang .
ANNALS OF HEMATOLOGY, 2014, 93 (08) :1371-1380
[7]   Identification of a Primary Target of Thalidomide Teratogenicity [J].
Ito, Takumi ;
Ando, Hideki ;
Suzuki, Takayuki ;
Ogura, Toshihiko ;
Hotta, Kentaro ;
Imamura, Yoshimasa ;
Yamaguchi, Yuki ;
Handa, Hiroshi .
SCIENCE, 2010, 327 (5971) :1345-1350
[8]   High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide [J].
Jonasova, Anna ;
Bokorova, Radka ;
Polak, Jaroslav ;
Vostry, Martin ;
Kostecka, Arnost ;
Hajkova, Hana ;
Neuwirtova, Radana ;
Siskova, Magda ;
Sponerova, Dana ;
Cermak, Jaroslav ;
Mikulenkova, Dana ;
Cervinek, Libor ;
Brezinova, Jana ;
Michalova, Kyra ;
Fuchs, Ota .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (01) :27-34
[9]   Cereblon contributes to the development of pulmonary fibrosis via inactivation of adenosine monophosphate-activated protein kinase α1 [J].
Kang, Hyo Jae ;
Lee, Kyung Jin ;
Woo, Jisu ;
Kim, Jiyeon ;
Kim, Yun Kyu ;
Lee, Chang-Hoon ;
Yoo, Chul-Gyu ;
Lee, Kyoung-Hee .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (05) :885-893
[10]   Ablation of cereblon attenuates myocardial ischemia-reperfusion injury [J].
Kim, Jooyeon ;
Lee, Kwang Min ;
Park, Chul-Seung ;
Park, Woo Jin .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 447 (04) :649-654